\u827e\u4f2f\u7ef4AbbVie\uff08NYSE:ABBV\uff09<\/a>\u3002<\/p>\n\u827e\u4f2f\u7ef4\u8fd1\u671f\u7684\u8d22\u52a1\u6570\u636e\u53ef\u80fd\u6709\u4e00\u70b9\u8bef\u5bfc\u6027<\/h2>\n
\u8ddf\u82f1\u4f1f\u8fbe\u76f8\u6bd4\uff0c\u827e\u4f2f\u7ef4\u4e0d\u4ec5\u70ed\u5ea6\u4e0d\u884c\uff0c\u80a1\u4ef7\u6700\u8fd1\u751a\u81f3\u8fd8\u662f\u4e0b\u8dcc\u7684\uff0c\u539f\u56e0\u662f\u8be5\u516c\u53f8\u7684\u589e\u901f\u4e0d\u7406\u60f3\u3002\u4eca\u5e74\u524d3\u4e2a\u6708\uff0c\u8be5\u516c\u53f8\u6536\u5165\u603b\u8ba1123\u4ebf\u7f8e\u5143\uff0c\u540c\u6bd4\u589e\u5e45\u8fd8\u4e0d\u52301%\u3002<\/p>\n
\u4f46\u8fd9\u4e2a\u6570\u636e\u53ef\u80fd\u4f1a\u6709\u4e00\u70b9\u8bef\u5bfc\u6027\u3002\u827e\u4f2f\u7ef4\u7684\u6536\u5165\u589e\u901f\u4e4b\u6240\u4ee5\u4e0d\u592a\u597d\u770b\uff0c\u5f88\u91cd\u8981\u7684\u539f\u56e0\u662f\u8be5\u516c\u53f8\u7684\u7545\u9500\u836f\uff0c\u7c7b\u98ce\u6e7f\u6027\u5173\u8282\u708e\u836f\u7269Humira\u7684\u4e13\u5229\u6743\u4fdd\u62a4\u4e27\u5931\uff0c\u9500\u552e\u989d\u4e0b\u964d\u8fd136%\u81f3\u4e0d\u523023\u4ebf\u7f8e\u5143\u3002\u6240\u5e78\u7684\u662f\uff0cSkyrizi\u548cRinvoq\u8fd9\u4e24\u6b3e\u514d\u75ab\u836f\u7269\u6709\u80fd\u529b\u5f25\u8865\u8fd9\u4e00\u6536\u5165\u7f3a\u53e3\uff0c\u8fc7\u53bb\u4e00\u5b63\u5ea6\u7684\u5408\u8ba1\u6536\u5165\u8fbe\u5230\u4e8631\u4ebf\u7f8e\u5143\uff0c\u540c\u6bd4\u589e\u901f\u5206\u522b\u9ad8\u8fbe48%\u548c59%\u3002<\/p>\n
\u827e\u4f2f\u7ef4\u7684\u589e\u957f\u6f5c\u529b\u53ef\u671f<\/h2>\n
\u827e\u4f2f\u7ef4\u8fd8\u4e00\u76f4\u6295\u8d44\u672a\u6765\u7684\u589e\u957f\u673a\u4f1a\uff0c\u6bd4\u5982\u8bf4\u4eca\u5e74\u65e9\u4e9b\u65f6\u5019\u5b8c\u6210\u4e86\u5bf9\u6297\u4f53\u5076\u8054\u836f\u7269\uff08ADC\uff09\u751f\u4ea7\u5546ImmunoGen 100\u4ebf\u7f8e\u5143\u7684\u6536\u8d2d\uff0c\u540c\u65f6\u8ba1\u521287\u4ebf\u7f8e\u5143\u6536\u8d2dCerevel Therapeutics\uff0c\u5f3a\u5316\u516c\u53f8\u7684\u795e\u7ecf\u7cfb\u7edf\u79d1\u5b66\u7814\u53d1\u7ba1\u7ebf\u548c\u4e1a\u52a1\u3002\u827e\u4f2f\u7ef4\u7684\u9996\u5e2d\u6267\u884c\u5b98Richard A. Gonzalez\u76f8\u4fe1\uff0c\u516c\u53f8\u7684\u6295\u8d44\u4e0d\u4e45\u5c31\u5c06\u8fce\u6765\u6536\u83b7\uff0c\u4ed6\u9884\u8ba1\u516c\u53f82025\u5e74\u5c06\u6062\u590d\u5f3a\u52b2\u589e\u957f\uff0c2030\u5e74\u4e4b\u524d\u7684\u5e74\u590d\u5408\u589e\u957f\u7387\uff08CAGR\uff09\u53ef\u4ee5\u8fbe\u5230\u9ad8\u7b49\u4e2a\u4f4d\u6570\u3002<\/p>\n
\u5bf9\u4e8e\u6210\u957f\u578b\u6295\u8d44\u8005\u6765\u8bf4\uff0c\u8fd9\u4e00\u589e\u901f\u6c34\u5e73\u53ef\u80fd\u4f9d\u7136\u6709\u70b9\u4f4e\uff0c\u4f46\u597d\u5728\u827e\u4f2f\u7ef4\u62e5\u6709\u5927\u91cf\u7684\u81ea\u7531\u73b0\u91d1\uff0c\u8fc7\u53bb3\u5e74\u521b\u9020\u4e86\u8d85\u8fc7680\u4ebf\u7f8e\u5143\u7684\u81ea\u7531\u73b0\u91d1\u6d41\uff0c\u4ece\u800c\u652f\u6301\u516c\u53f8\u672a\u6765\u7684\u6536\u8d2d\u53ca\u5176\u4ed6\u673a\u4f1a\u3002<\/p>\n
\u4f30\u503c\u548c\u80a1\u606f<\/h2>\n
\u4eca\u5e74\u8fc4\u4eca\uff0c\u827e\u4f2f\u7ef4\u80a1\u4ef7\u4ec5\u4e0a\u6da85%\uff0c\u4f46\u52a8\u6001\u5e02\u76c8\u7387\u4e5f\u53ea\u670915\uff0cPEG\uff08\u5e02\u76c8\u7387\u76f8\u5bf9\u76c8\u5229\u589e\u957f\u6bd4\u7387\uff09\u6bd4\u7387\u66f4\u662f\u4f4e\u81f30.4\u3002\u76f8\u6bd4\u4e4b\u4e0b\uff0c\u82f1\u4f1f\u8fbe\u7684PEG\u6bd4\u7387\u57281.3\u9644\u8fd1\u3002\u9664\u4e86\u4f4e\u4f30\u503c\uff0c\u8be5\u80a1\u76ee\u524d\u80a1\u606f\u7387\u8fbe3.8%\uff0c\u662f\u6807\u666e500\u6307\u6570\u5e73\u5747\u6c34\u5e731.4%\u7684\u4e24\u500d\u591a\u3002<\/p>\n
\u827e\u4f2f\u7ef4\u503c\u5f97\u4e70\u5165\u5e76\u6301\u6709<\/h2>\n
\u867d\u7136\u8fd1\u671f\u7684\u4e1a\u7ee9\u4e0d\u592a\u51fa\u8272\uff0c\u4f46\u6211\u4eec\u4f9d\u7136\u6709\u7406\u7531\u957f\u671f\u770b\u597d\u827e\u4f2f\u7ef4\u3002\u6295\u8d44\u8005\u53ef\u4ee5\u4e00\u8fb9\u6536\u53d6\u80a1\u606f\u6536\u5165\uff0c\u4e00\u8fb9\u7b49\u5f85\u516c\u53f8\u4e1a\u7ee9\u7684\u5411\u597d\uff0c\u4ece\u800c\u5e26\u52a8\u80a1\u4ef7\u7684\u4e0a\u6da8\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"
\u82f1\u4f1f\u8fbeNVIDIA\uff08NASDAQ:NVDA\uff09\u662f\u4e00\u53ea\u4f18\u8d28\u7684\u6210\u957f\u80a1\uff0c\u5c24\u5176\u662f\u5bf9\u957f\u671f\u6295\u8d44\u8005\u6765\u8bf4\u3002\u4f46\u7f8e\u4e2d\u4e0d\u8db3\u7684\u662f\uff0c\u8be5\u80a1\u52a8 […]<\/p>\n","protected":false},"author":27,"featured_media":475562,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[1521,430],"tags":[455,2155,925,1859],"class_list":["post-498172","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1521","category-trends-strategies-zh-hans","tag-455","tag-2155","tag-925","tag-1859","sectors-life-science-zh-hans","sectors-technology-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/498172","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/27"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=498172"}],"version-history":[{"count":1,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/498172\/revisions"}],"predecessor-version":[{"id":498177,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/498172\/revisions\/498177"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/475562"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=498172"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=498172"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=498172"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}